It can be triggered by various cellular conditions including nucleotide shortage, the presence of abnormal chromosome structures, or activation of oncogenes such as MYC, RAS, or CYCLIN-E and contributes to the induction of structural chromosome aberrations that are frequently seen in cancer (Zeman & Cimprich, 2014; Igarashi et al, 2024). This evidence concerns the gene MYC and cancer.